Skip to main navigation Skip to search Skip to main content

Progressive multifocal leukoencephalopathy in a lung transplant recipient

  • Hadassah University Medical Centre
  • Rabin Medical Center Israel
  • Tel Aviv University

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Progressive multifocal leukoencephalopathy (PML) is a sub-acute, demyelinating disease of the brain caused by a human polyomavirus. We describe a patient with the onset of PML 7 months after lung transplantation. The patient was treated with immunosuppressive modulation and cidofovir, a new anti-viral therapy for PML, with stabilization of the symptoms. We also review the 4 additional reports in the literature of PML after heart and lung transplantation. Progressive multifocal leukoencephalopathy may become more prevalent as the population of heart and lung transplantation recipients increases.

Original languageEnglish
Pages (from-to)946-950
Number of pages5
JournalJournal of Heart and Lung Transplantation
Volume22
Issue number8
DOIs
StatePublished - 1 Aug 2003

Fingerprint

Dive into the research topics of 'Progressive multifocal leukoencephalopathy in a lung transplant recipient'. Together they form a unique fingerprint.

Cite this